Latest Announcements

Kuantum Papers Limited has informed the Exchange about Credit Rating- New, where India Ratings and Research (Ind-Ra) has assigned credit ratings to the Company's Bank Loans facilities and Fixed Deposits.

SMS Pharmaceuticals Limited has announced its financial results for the quarter ended June 30, 2026, with a standalone profit before tax of Rs. 2,814.42 lakhs. The company has also approved the re-appointment of its Managing Director, Mr. Ramesh Babu Potluri, for a term of 5 years. Additionally, the company has approved giving a loan to its subsidiary, SMS Peptides Private Limited, up to an aggregate amount of Rs. 50 crores.

Ram Ratna Wires Limited has informed the Exchange about Investor Presentation, which includes unaudited financial results for the quarter ended on June 30, 2026.

Star Health and Allied Insurance Company Limited has published unaudited standalone financial results for the quarter ended June 30, 2026, in compliance with SEBI regulations.

MAS Financial Services Limited has received approval from the Unique Identification Authority of India (UIDAI) for its appointment as a Sub-Authentication User Agency (Sub-AUA) and Sub-eKYC User Agency (Sub-KUA) under Protean eGov Technologies Limited.

Valecha Engineering Limited has informed the Exchange regarding an unspecified update.

Best Agrolife Limited has informed the Exchange about the link of recording of its earnings conference call for the financial year 2026-27.

Info Edge (India) Limited has informed the Exchange about a conference call regarding its financial results for the quarter ended June 30, 2026.

India Glycols Limited has informed the Exchange regarding a material update in connection with Ennature Bio Pharma Limited, a wholly owned subsidiary, regarding the appointment of Shri Akshay Bansal as Additional Director (Executive Director) & Key Managerial Personnel.

Rajasthan Global Securities Private Ltd has submitted a disclosure under SEBI Takeover Regulations to the NSE.

Jupiter Life Line Hospitals Limited has adopted a new line of business by acquiring 100% of the equity share capital of Sulcus Private Limited for ₹3.78 crore, and has also appointed a new Chief Financial Officer.

Lupin Limited has received approval from the US FDA for its Abbreviated New Drug Application for Diazepam Injection USP, 10 mg/2 mL (5 mg/mL), Single-Dose Prefilled Syringes.

India Glycols Limited has informed the Exchange regarding the cessation of Mr. Akshay Bansal as Other of the company w.e.f. July 30, 2026, and his appointment as Additional Director (Executive Director) & Key Managerial Personnel at Ennature Bio Pharma Limited, a wholly owned subsidiary of the company.

Shadowfax Technologies Limited has informed the Exchange about grant of Employee Stock Options under Shadowfax Technologies Limited- Employee Stock Option Plan - 2016.

Nuvama Wealth Management Limited has made the audio recording of its earnings conference call for Q1 FY26-27 available on its website.

Jindal Worldwide Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the Limited Review Report issued by the Statutory Auditors. The Board of Directors has considered and approved other businesses as per the agenda of the meeting.

Jupiter Life Line Hospitals Limited has announced its unaudited financial results for the quarter ended June 30, 2026, along with the appointment of a new Chief Financial Officer and the acquisition of a subsidiary.

Jupiter Life Line Hospitals Limited has appointed Mr. Harshad Purani as Chief Financial Officer (CFO) of the company, effective July 31, 2026. The company has also approved the unaudited financial results for the quarter ended June 30, 2026, and has acquired 100% of the equity share capital of Sulcus Private Limited.

Angel One Limited has informed the Exchange regarding the allotment of 168488 shares to eligible employees under the Angel Broking Employee Long Term Incentive Plan 2021.

JSW Steel Limited has achieved global investment grade status with Moody's Baa3 rating, citing sustained improvement in its credit profile, cost-competitive operations, and material debt reduction.